# Zhejiang Yongtai Pharmaceutical Co. Ltd – FDA Inspection, Mar 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-yongtai-pharmaceutical-co-ltd/5ef0335d-e8f3-4562-a0c7-d59fc968fb04
Source feed: FDA_Inspections

> FDA inspection 1087304 of Zhejiang Yongtai Pharmaceutical Co. Ltd, March 22, 2019. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087304
- Company Name: Zhejiang Yongtai Pharmaceutical Co. Ltd
- Inspection Date: 2019-03-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1265344 - 2025-03-14](https://www.keypedia.com/records/fda_inspections/zhejiang-yongtai-pharmaceutical-co-ltd/693b2efb-b150-42e5-9274-afb536c81c19)
- [FDA Inspection 1074808 - 2018-11-03](https://www.keypedia.com/records/fda_inspections/zhejiang-yongtai-pharmaceutical-co-ltd/59da4488-d4f2-415f-a2b4-52290807a739)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kham-phommachanh/cc7e728e-d2a1-469d-be3a-4f5fdd43b2dc)

Company: https://www.keypedia.com/companies/zhejiang-yongtai-pharmaceutical-co-ltd/6a221649-e0e9-4191-876a-0fb3d0653677

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c